Doesn't this likely eliminate BIIB as a potential MNTA partner? I guess there could be some sort of 3 party structure with MNTA technology, BIIB manufactuing, and big pharma sales/marketing...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.